Spatiotemporal dynamics and heterogeneity of renal lymphatics in mammalian development and cystic kidney disease

Abstract

Heterogeneity of lymphatic vessels during embryogenesis is critical for organ-specific lymphatic function. Little is known about lymphatics in the developing kidney, despite their established roles in pathology of the mature organ. We performed three-dimensional imaging to characterize lymphatic vessel formation in the mammalian embryonic kidney at single-cell resolution. In mouse, we visually and quantitatively assessed the development of kidney lymphatic vessels, remodeling from a ring-like anastomosis under the nascent renal pelvis, a site of VEGF-C expression, to form a patent vascular plexus. We identified a heterogenous population of lymphatic endothelial cell clusters in mouse and human embryonic kidneys. Exogenous VEGF-C expanded the lymphatic population in explanted mouse embryonic kidneys. Finally, we characterized complex kidney lymphatic abnormalities in a genetic mouse model of polycystic kidney disease. Our study provides novel insights into the development of kidney lymphatic vasculature; a system which likely has fundamental roles in renal development, physiology and disease.

Data availability

The FIJI script used for segmenting and binarizing PROX1+/LYVE1+ cells has been provided as Source code file 1. All raw numerical data and results of statistical tests are attached as Source Data files with the appropriate figure.

Article and author information

Author details

  1. Daniyal J Jafree

    Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8235-0394
  2. Dale Moulding

    Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  3. Maria Kolatsi-Joannou

    Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Nuria Perretta Tejedor

    Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Karen L Price

    Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Natalie J Milmoe

    Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Claire L Walsh

    Centre for Advanced Biomedical Imaging, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  8. Rosa Maria Correra

    UCL Institute of Ophthalmology, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. Paul JD Winyard

    Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Peter C Harris

    Division of Nephrology and Hypertension, Mayo Clinic, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Christiana Ruhrberg

    UCL Institute of Ophthalmology, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  12. Simon Walker-Samuel

    Centre for Advanced Biomedical Imaging, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  13. Paul R Riley

    Department of Physiology, Anatomy and Genetics, University of Oxford, Oxford, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9862-7332
  14. Adrian S Woolf

    School of Biological Sciences, Faculty of Biology Medicine and Health, University of Manchester, Manchester, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5541-1358
  15. Peter Scambler

    Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  16. David A Long

    Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom
    For correspondence
    d.long@ucl.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6580-3435

Funding

UCL Great Ormond Street Institute of Child Health (Child Health Research Studentship)

  • Daniyal J Jafree
  • Peter Scambler
  • David A Long

British Heart Foundation (RG/15/14/31880)

  • Peter Scambler

Kidney Research UK (Paed_RP_10_2018)

  • Daniyal J Jafree
  • Adrian S Woolf
  • David A Long

Kidney Research UK (IN_012_2019)

  • Daniyal J Jafree
  • David A Long

University College London MB/PhD Programme (MB/PhD Studentship)

  • Daniyal J Jafree

Medical Research Council (MR/P018629/1)

  • David A Long

Medical Research Council (MR/L002744/1)

  • Adrian S Woolf

Medical Research Council (MR/K026739/1)

  • Adrian S Woolf

British Heart Foundation (FS/19/14/34170)

  • Rosa Maria Correra

Diabetes UK (15/0005283)

  • David A Long

NIHR Great Ormond Street Hospital Biomedical Research Centre Award (17DD08)

  • Dale Moulding

British Heart Foundation (CH/11/1/28798)

  • Paul R Riley

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Kari Alitalo, Wihuri Research Institute, Finland

Ethics

Animal experimentation: All experiments were carried out according to a UK Home Office project license (PPL: PE52D8C09) and were compliant with the UK Animals (Scientific Procedures) Act 1986.

Human subjects: Human fetal kidneys were obtained from the Human Developmental Biology Resource (http://www.hdbr.org), which obtains written consent from donors to collect, store and distribute human fetal material between 4-20PCW.

Version history

  1. Received: May 3, 2019
  2. Accepted: November 30, 2019
  3. Accepted Manuscript published: December 6, 2019 (version 1)
  4. Version of Record published: January 8, 2020 (version 2)

Copyright

© 2019, Jafree et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,304
    Page views
  • 536
    Downloads
  • 32
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Daniyal J Jafree
  2. Dale Moulding
  3. Maria Kolatsi-Joannou
  4. Nuria Perretta Tejedor
  5. Karen L Price
  6. Natalie J Milmoe
  7. Claire L Walsh
  8. Rosa Maria Correra
  9. Paul JD Winyard
  10. Peter C Harris
  11. Christiana Ruhrberg
  12. Simon Walker-Samuel
  13. Paul R Riley
  14. Adrian S Woolf
  15. Peter Scambler
  16. David A Long
(2019)
Spatiotemporal dynamics and heterogeneity of renal lymphatics in mammalian development and cystic kidney disease
eLife 8:e48183.
https://doi.org/10.7554/eLife.48183

Share this article

https://doi.org/10.7554/eLife.48183

Further reading

    1. Developmental Biology
    2. Immunology and Inflammation
    Amir Hossein Kayvanjoo, Iva Splichalova ... Elvira Mass
    Research Article Updated

    During embryogenesis, the fetal liver becomes the main hematopoietic organ, where stem and progenitor cells as well as immature and mature immune cells form an intricate cellular network. Hematopoietic stem cells (HSCs) reside in a specialized niche, which is essential for their proliferation and differentiation. However, the cellular and molecular determinants contributing to this fetal HSC niche remain largely unknown. Macrophages are the first differentiated hematopoietic cells found in the developing liver, where they are important for fetal erythropoiesis by promoting erythrocyte maturation and phagocytosing expelled nuclei. Yet, whether macrophages play a role in fetal hematopoiesis beyond serving as a niche for maturing erythroblasts remains elusive. Here, we investigate the heterogeneity of macrophage populations in the murine fetal liver to define their specific roles during hematopoiesis. Using a single-cell omics approach combined with spatial proteomics and genetic fate-mapping models, we found that fetal liver macrophages cluster into distinct yolk sac-derived subpopulations and that long-term HSCs are interacting preferentially with one of the macrophage subpopulations. Fetal livers lacking macrophages show a delay in erythropoiesis and have an increased number of granulocytes, which can be attributed to transcriptional reprogramming and altered differentiation potential of long-term HSCs. Together, our data provide a detailed map of fetal liver macrophage subpopulations and implicate macrophages as part of the fetal HSC niche.

    1. Developmental Biology
    2. Neuroscience
    Smrithi Prem, Bharati Dev ... Emanuel DiCicco-Bloom
    Research Article Updated

    Autism spectrum disorder (ASD) is defined by common behavioral characteristics, raising the possibility of shared pathogenic mechanisms. Yet, vast clinical and etiological heterogeneity suggests personalized phenotypes. Surprisingly, our iPSC studies find that six individuals from two distinct ASD subtypes, idiopathic and 16p11.2 deletion, have common reductions in neural precursor cell (NPC) neurite outgrowth and migration even though whole genome sequencing demonstrates no genetic overlap between the datasets. To identify signaling differences that may contribute to these developmental defects, an unbiased phospho-(p)-proteome screen was performed. Surprisingly despite the genetic heterogeneity, hundreds of shared p-peptides were identified between autism subtypes including the mTOR pathway. mTOR signaling alterations were confirmed in all NPCs across both ASD subtypes, and mTOR modulation rescued ASD phenotypes and reproduced autism NPC-associated phenotypes in control NPCs. Thus, our studies demonstrate that genetically distinct ASD subtypes have common defects in neurite outgrowth and migration which are driven by the shared pathogenic mechanism of mTOR signaling dysregulation.